Is there protective immunity after an Omicron infection?
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 593
- Publication type:
- Article
Works matching IS 11884169 AND DT 2022 AND VI 48 AND IP 11/12
Results: 13
1
2
Response to letter: "Circular logic and flawed modelling compromises non-pharmaceutical intervention paper's conclusions".
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 588
- Publication type:
- Article
3
Summary of the National Advisory Committee on Immunization (NACI) Rapid Response: Updated interim guidance on Imvamune in the context of ongoing monkeypox outbreaks.
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 580, doi. 10.14745/ccdr.v48i1112a11
- By:
- Publication type:
- Article
4
Prevalence of antimicrobial-resistant organisms in smaller Canadian hospitals: Community, Rural, and Northern Acute Care Point Prevalence (CNAPP-19) Survey, 2019.
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 559, doi. 10.14745/ccdr.v48i1112a09
- By:
- Publication type:
- Article
5
Antimicrobial susceptibilities of Neisseria gonorrhoeae in Canada, 2020.
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 571, doi. 10.14745/ccdr.v48i1112a10
- By:
- Publication type:
- Article
6
Understanding Canadians' knowledge, attitudes and practices related to antimicrobial resistance and antibiotic use: Results from public opinion research.
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 550, doi. 10.14745/ccdr.v48i1112a08
- By:
- Publication type:
- Article
7
National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019.
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 540, doi. 10.14745/ccdr.v48i1112a07
- By:
- Publication type:
- Article
8
Hospital and related resource costs associated with antimicrobial-resistant infections in Canada, 2019.
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 529, doi. 10.14745/ccdr.v48i1112a06
- By:
- Publication type:
- Article
9
Overview of Canada's Antimicrobial Resistance Network (AMRNet): A data-driven One Health approach to antimicrobial resistance surveillance.
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 522, doi. 10.14745/ccdr.v48i1112a05
- By:
- Publication type:
- Article
10
The Canadian Nosocomial Infection Surveillance Program: Keeping an eye on antimicrobial resistance in Canadian hospitals since 1995.
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 506, doi. 10.14745/ccdr.v48i1112a03
- Publication type:
- Article
11
Moving the needle on dental antibiotic overuse in Canada post COVID-19.
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 502, doi. 10.14745/ccdr.v48i1112a02
- By:
- Publication type:
- Article
12
Short-course antibiotic therapy: The next frontier in antimicrobial stewardship.
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 496, doi. 10.14745/ccdr.v48i1112a01
- By:
- Publication type:
- Article
13
Antibiotic prescribing and antimicrobial stewardship in long-term care facilities: Past interventions and implementation challenges.
- Published in:
- Canada Communicable Disease Report, 2022, v. 48, n. 11/12, p. 512, doi. 10.14745/ccdr.v48i1112a04
- By:
- Publication type:
- Article